Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study

Neuroscience

Volumn 71, Issue 4, 1996, Pages 903-912

  Vila, M ^a   Levy, R ^a   Herrero, M T ^b   Faucheux, B ^a   Obeso, J A ^c   Agid, Y ^a   Hirsch, E C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Enzyme histochemistry; L DOPA; Monkeys; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C OXIDASE; LEVODOPA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; GLOBUS PALLIDUS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; MALE; MONKEY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 0029944564     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00549-8     Document Type: Article

References (52)

1. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
2. Alexander G. E. and Crutcher M. D. (1990) Functional architecture of the basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266-271.
3. Aziz T. Z., Peggs D., Sambrook M. A. and Crossman A. R. (1991) Lesions of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Movement Disord. 4, 288-292.
4. Baker D. M. and Santer R. M. (1990) Development of a quantitative histochemical method for determination of succinate dehydrogenase activity in autonomic neurons and its application to the study of aging in the autonomic nervous system. J. Histochem. Cytochem. 38, 525-531.
5. Benazzouz A., Gross Ch., Feger J., Boraud T. and Bioulac B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5, 382-389.
6. Bergman H., Wichmann T. and DeLong M. R. (1990) Reversal of experimental Parkinsonism by lesions of the subthalamic nucleus. Science 249, 1436-1438.
7. Blandini F. and Greenamyre J. T. (1995) Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia. Brain Res. 669, 59-66.
8. Borowsky I. W. and Collins R. C. (1989) Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. J. comp. Neurol. 288, 401-413.
9. Crossman A. R. (1989) Neural mechanisms in disorders of movement. Comp. Biochem. Physiol. 93, 141-149.
10. 14C]cyanide tissue labeling in vivo. J. cerebr. Blood Flow Metab. 6, 8-14.
11. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
12. Dietrich W. D., Durham D., Lowry O. H. and Woolsey T. A. (1982) "Increased" sensory stimulation leads to changes in energy-related enzymes in the brain. J. Neurosci. 2, 1608-1613.
13. DiFiglia M., Graveland G. A. and Schiff L. (1987) Cytochrome oxidase activity in the rat caudate nucleus: light and electron microscopic observations. J. comp. Neurol. 255, 137-145.
14. Gerfen C. R., Engber T. M., Mahan L. C., Zvi S., Chase T. N., Monsma F. J. and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
15. Gonzalez-Lima F. and Garrosa M. (1991) Quantitative histochemistry of cytochrome oxidase in rat brain. Neurosci. Lett. 123, 251-253.
16. Gonzalez-Lima F. and Cada A. (1994) Cytochrome oxidase activity in the auditory system of the mouse: a qualitative and quantitative histochemical study. Neuroscience 63, 559-578.
17. Graybiel A. M. and Ragsdale C. W. (1978) Histochemically distinct compartments in the striatum of human, monkey and cat demonstrated by acetylcholinesterase staining. Proc. natn. Acad. Sci. U.S.A. 75, 5723-5726.
18. Guridi J., Herrero M.-T., Luquin M. R., Guillen J., Ruberg M., Vila M., Laguna J., Javoy-Agid F., Agid Y., Hirsch E. C. and Obeso J. A. (1996) Decreased GAD mRNA expression in internal pallidum and substantia nigra pars reticulata neurons after subthalamotomy. Brain (submitted).
19. Herrero M.-T., Levy R., Ruberg M., Luquin M. R., Villares J., Guillen J., Faucheux B., Javoy-Agid F., Guridi J., Agid Y., Obeso J. A. and Hirsch E. C. (1996) Consequence of nigrostriatal denervation and L-DOPA therapy on the expression of glutamic acid decarboxylase (GAD) messenger RNA in the pallidum. Neurology in press.
20. Herrero M.-T., Augood S. J., Hirsch E. C., Javoy-Agid F., Luquin M. R., Agid Y., Obeso J. A. and Emson P. C. (1995) Effects of L-DOPA on pre-proenkephalin and pre-protachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 68, 1189-1198.
21. Herrero M.-T., Levy R., Ruberg M., Javoy-Agid F., Luquin M. R., Agid Y., Hirsch E. C. and Obeso J. A. (1996) GAD mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease. In Advances in Neurology (ed. Battistin L.). Raven Press, New York (in press).
22. Hevner R. F. and Wong-Riley M. T. T. (1991) Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 11, 1942-1958.
23. +-ATPase. Neurosci. Lett. 138, 188-192.
24. Hevner R. F., Liu S. and Wong-Riley M. T. T. (1995) A metabolic map of cytochrome oxidase in the rat brain; histochemical, densitometric and biochemical studies. Neuroscience 65, 313-342.
25. Hornykiewicz O. (1966) Dopamine (3-hydroxytyramine) and brain functions. Pharmac. Rev. 18, 925-964.
26. Kincaid A. E., Albin R. L., Newman S. W., Penney J. B. and Young A. B. (1992) 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience 51, 705-718.
27. Klockgether T. and Turski L. (1989) Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci. 12, 285-286.
28. 67 mRNA. Eur. J. Neurosci. 7, 1199-1209.
29. Liu Y., Gu Q. and Cynader M. S. (1993) An improved staining technique for cytochrome C oxidase. J. Neurosci. Meth. 49, 181-184.
30. Luquin M. R., Herrero M. T. and Obeso J. A. (1992) Parkinsonismo inducido por MPTP como modelo experimental de Enfermedad de Parkinson: Similitudes y diferencias. Neurologia. 31, 551-554.
31. Miller W. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of Parkinsonism. In The Basal Ganglia II (eds Carpenter M. B. and Jayaraman A.), pp. 414-427. Plenum, New York.
32. Mitchell I. J., Clarke C. E., Boyce S., Robertson R. G., Peggs D. E., Sambrook M. A. and Crossman A. R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32, 213-226.
33. Porter R. H. P., Greene J. G., Higgins D. S. Jr and Greenamyre J. T. (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J. Neurosci. 14, 7192-7199.
34. Robledo P. and Feger J. (1990) Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res. 518, 47-54.
35. 14C]2-deoxyglucose. J. comp. Neurol. 177, 335-360.
36. Sellal F., Hirsch E., Lisovoski F., Mutschler V., Collard M. and Marescaux C. (1992) Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 42, 255-256.
37. Smith Y. and Parent A. (1988) Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivity. Brain Res. 453, 353-356.
38. Soghomonian J. J. and Chesselet M. F. (1992) Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse 11, 124-133.
39. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
40. Sokoloff L. (1984) Metabolic Probes of Central Nervous System Activity in Experimental Animals and Man. Sinauer, Sunderland, MA.
41. Tzagournissakis M., Dermon C. R. and Savaki H. E. (1994) Functional metabolic mapping of the rat brain during unilateral electrical stimulation of the subthalamic nucleus. J. cerebr. Blood Flow Metab. 14, 132-144.
42. Vernier P., Julien J. F., Rataboul P., Fourrier O., Feuerstein C. and Mallet J. (1988) Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat. J. Neurochem. 51, 1375-1380.
43. Vila M., Herrero M.-T., Levy R., Faucheux B., Ruberg M., Guillen J., Luquin M. R., Guridi J., Javoy-Agid F., Agid Y., Obeso J. A. and Hirsch E. C. (1996) Consequences of nigrostriatal denervation on the GABAergic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes. Neurology (in press).
44. Weiss-Wunder L. T. and Chesselet M. F. (1990) Heterogeneous distribution of cytochrome oxidase activity in the rat substantia nigra: correlation with tyrosine hydroxylase and dynorphin immunoreactivities. Brain Res. 529, 269-276.
45. Wichmann T. and DeLong M. R. (1993) Pathophysiology of parkinsonian motor abnormalities. In Advances in Neurology (eds Narabayashi H., Nagatsu T., Yanagisawa N. and Mizuno Y.), Vol. 60, pp. 53-61. Raven Press, New York.
46. Wong-Riley M. T. T., Merzenich M. M. and Leake P. A. (1978) Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity. Brain Res. 141, 185-192.
47. Wong-Riley M. T. T. (1979) Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res. 171, 11-28.
48. Wong-Riley M. T. T. and Welt C. (1980) Histochemical changes in cytochrome oxidase of cortical barrels after vibrissal removal in neonatal and adult mice. Proc. natn. Acad. Sci. U.S.A. 77, 2333-2337.
49. Wong-Riley M. T. T., Walsh E. M., Leake-Jones R. A. and Merzenich M. M. (1981) Maintenance of neuronal activity by electrical stimulation of unilaterally deafened cats demonstrable with cytochrome oxidase technique. Ann. Otol. Rhinol. Lar. 90, Suppl. 82, 30-32.
50. Wong-Riley M. T. T. and Carroll E. W. (1984) Effect of impulse blockage on cytochrome oxidase activity in monkey visual system. Nature 307, 262-264.
51. Wong-Riley M. T. T. (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12, 94-101.
52. Yahr M. D. (1993) Parkinson's disease: the L-dopa era. In Advances in Neurology (eds Narabayashi H., Nagatsu T., Yanagisawa N. and Mizuno Y.), Vol. 60, pp. 11-17. Raven Press, New York.